The Swiss Hepatitis C Cohort Study (SCCS) is a systematic longitudinal study, collecting data on people in Switzerland who are infected with hepatitis C. The long-term objectives of the SCCS are:
- to establish an infrastructure and evaluation network for the advancement of clinical and biomedical research on the natural progression of hepatitis C infections (HCV)
- to optimise and standardise treatment of HCV-infected patients
The SCCS will deliver information on which factors influence the progression of HCV infections, in order to enable future treatment decisions and predictions of what the burden of HCV-related illnesses in the general population will be. It will also provide epidemiological data to complement the mandatory national monitoring system of the Federal Office of Public Health (FOPH).
David Semela, Dr. med. (Chairman), Dr. med. (Chairman), Gastroenterology and Hepatology, Hospital of the Canton of St.Gallen
Philip Bruggmann, PD Dr. med., Head of General Internal Medicine
Arud Centre for Addiction Medicine
Swiss National Science Foundation and others